| # | Drug | Count |
|---|---|---|
| 0 | UPADACITINIB | 141 |
| 1 | RISANKIZUMAB-RZAA | 116 |
| 2 | ADALIMUMAB | 69 |
| 3 | INFLIXIMAB-DYYB | 26 |
| 4 | INFLIXIMAB | 16 |
| 5 | PREDNISONE | 14 |
| 6 | METHOTREXATE SODIUM | 11 |
| 7 | ERGOCALCIFEROL | 10 |
| 8 | METHOTREXATE | 8 |
| 9 | LISINOPRIL | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 26 | 0.0075 |
| 1 | CALCIUM ANTACID | 1 | 0.0023 |
| 2 | UPADACITINIB | 141 | 0.0017 |
| 3 | LISOCABTAGENE MARALEUCEL | 1 | 0.0011 |
| 4 | MITAPIVAT | 1 | 0.0008 |
| 5 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 6 | SILODOSIN | 2 | 0.0005 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 4 | 0.0005 |
| 8 | INSULIN LISPRO-AABC | 1 | 0.0005 |
| 9 | SODIUM FERRIC GLUCONATE COMPLEX | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-23 Antagonist [EPC] | 119 | 0.0011 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 2 | Janus Kinase Inhibitor [EPC] | 141 | 0.0009 |
| 3 | Pyruvate Kinase Activator [EPC] | 1 | 0.0008 |
| 4 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 5 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 6 | Provitamin D2 Compound [EPC] | 10 | 0.0003 |
| 7 | Phosphate Binder [EPC] | 1 | 0.0003 |
| 8 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |